About Us | Contact

Jeffrey Milbrandt

Molecular Genetic Pathology NPI1699043703
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$73,337.71
from 19 payments in the last 6 years

Total Cash or Cash Equivalent

$72,350.00
from 12 payments in the last 6 years

Total In-kind Items & Services

$987.71
from 7 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
10/05/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 819159519
02/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 819159515
09/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 818576497
07/19/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 818576495
06/21/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 818563727
04/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 818563725
08/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 818563469
03/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 818563467
10/27/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 818562941
05/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 818554043
01/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $6250.00 Details
Payment from Eli Lilly and Company
Payment Record ID 818554041
06/29/2016 General (Non-Research) In-kind items and services Travel and Lodging $40.00 Details
Payment from Vertex Pharmaceuticals Incorporated
Payment Record ID 513031383
06/29/2016 General (Non-Research) In-kind items and services Travel and Lodging $25.00 Details
Payment from Vertex Pharmaceuticals Incorporated
Payment Record ID 513031381
06/29/2016 General (Non-Research) In-kind items and services Food and Beverage $21.40 Details
Payment from Vertex Pharmaceuticals Incorporated
Payment Record ID 513031379
06/29/2016 General (Non-Research) In-kind items and services Travel and Lodging $438.34 Details
Payment from Vertex Pharmaceuticals Incorporated
Payment Record ID 513031377
06/29/2016 General (Non-Research) In-kind items and services Travel and Lodging $30.00 Details
Payment from Vertex Pharmaceuticals Incorporated
Payment Record ID 513031375
06/29/2016 General (Non-Research) In-kind items and services Travel and Lodging $40.00 Details
Payment from Vertex Pharmaceuticals Incorporated
Payment Record ID 513031373
06/29/2016 General (Non-Research) In-kind items and services Travel and Lodging $392.97 Details
Payment from Vertex Pharmaceuticals Incorporated
Payment Record ID 513031371
06/29/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $3600.00 Details
Payment from Vertex Pharmaceuticals Incorporated
Payment Record ID 513031369
;